CN1212128C - Blood circulation activating core - Google Patents
Blood circulation activating core Download PDFInfo
- Publication number
- CN1212128C CN1212128C CN 00113963 CN00113963A CN1212128C CN 1212128 C CN1212128 C CN 1212128C CN 00113963 CN00113963 CN 00113963 CN 00113963 A CN00113963 A CN 00113963A CN 1212128 C CN1212128 C CN 1212128C
- Authority
- CN
- China
- Prior art keywords
- weights
- unit
- radix
- core
- core bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000017531 blood circulation Effects 0.000 title abstract description 5
- 230000003213 activating effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 30
- 206010020772 Hypertension Diseases 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 241000237636 Pheretima Species 0.000 claims description 6
- 241000522620 Scorpio Species 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000009490 scorpio Substances 0.000 claims description 6
- 239000002390 adhesive tape Substances 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 206010043189 Telangiectasia Diseases 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 208000009056 telangiectasis Diseases 0.000 abstract description 2
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000081822 Uncaria gambir Species 0.000 abstract 1
- 210000000467 autonomic pathway Anatomy 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 210000003710 cerebral cortex Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 229910052595 hematite Inorganic materials 0.000 abstract 1
- 239000011019 hematite Substances 0.000 abstract 1
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 238000009987 spinning Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Finger-Pressure Massage (AREA)
Abstract
The present invention relates to a medicine permeator for treating hypertension through the yongquan acupoint of the sole of a human body. The present invention is provided with an ilk spinning face fabric core bag of which the inner part is provided with traditional Chinese medicine powder granule medicated core, and medicine which is filled in the medicated core is composed of gambir plant, oyster shells, hematite, cornu caprae hircus, earth worm, etc. which are beneficial to blood pressure reduction of the human body. When the present invention is used, activeated core is butted and attached to the sole, the medicinal ingredients can penetrate directly into skin meridians through the yongquan acupoint, and furthermore, the telangiectasia in the human body can be promoted; the blood circulation is quickened, the congestion state of the cerebral part of a patient is relieved, the functions of the autonomic nerves, the endocrine systems and the cerebral cortex of the patient are regulated, and the effect of pressure reduction is achieved.
Description
Content of the present invention belongs to medicine and field of medical article technology, relates to a kind of Drug therapy device of other pathological changes of health that can be used for preventing and treat hypertension and cause thus.
Hypertension is to be the commonly encountered diseases frequently-occurring disease of main clinical manifestation with the arteriotony rising, the branch that essential hypertension and secondary hypertension disease are arranged, the patient is many with dizziness, headache, hypertension, uncomfortable in chest, cardiopalmus etc. are main symptom, severe patient can be with sudden severe headache, blurring of vision, feel sick, vomiting, limbs generation tic sample trembles or of short duration hemiplegia is arranged, aphasia even symptom such as apoplexy takes place in sleep or when excited, the sensation extreme pain, it is to cause coronary heart disease, the principal element of brain soldier and brain fag, it gives society, family, relatives brought around the patient reached harm and stress are all quite big.In recent years, the hyperpietic who causes because of diseases such as lipid dysbolismus, arteriosclerosis, pyelonephritis among the crowd has the trend that sharply increases, and in each big or middle city of China and western countries this class patient's sickness rate just higher.The treatment hypertension does not still have desirable method on clinical medicine at present, though the Western medicine hypotensive effect is fast, but can not thoroughly cure, and some ingredients wherein also have numerous untoward reaction to human body taking the back for a long time, Chinese medicine then exists oral agents and takes deficiencies such as inconvenience, treatment limitation are big.How to prevent and treat hypertension effectively, become the problem that mankind nowadays presses for solution.
The objective of the invention is at the existing deficiency of state of the art, provide a kind of medicament composing prescription science, easy to prepare, have no side effect, can effectively treat hypertension and insecticide-applying way and be easy to receive the core bag that treatment hypertension Chinese medicine medicated powder is housed that absorbs for human body.
The preparation scheme of core bag product of the present invention and medicine comes from motherland's medical science about traditional determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs thoughts such as " inner disease outer treat ", " treating disease in the upper by managing the lower ", " treatment must aim at the pathogenesis of disease ", and it is that the present patent application people obtains by concentrated summary development according to clinical practice for many years and on modern pharmacology scientific experiments basis.
Motherland's traditional medicine think the vola be viscera through the feeling pulse place, the physiologic information of all internal organs of whole body all can by meridians inculcate come together in the foot; And modern medicine also once proposed relevant " foot reflex " theory, thought that people's brain and other internal organs all have corresponding " projection area " separately under vola.In the vola channel and collateral information, sufficient heart Yongquan acupoint is the important centrostigma of all internal organs physiologic information reactions of human body, and " spring " cave is it " well " cave of kidney meridian, and people's the heart, kidney, brain etc. main " projection area " all are positioned at around the arch of the foot Yongquan acupoint.Hypertension belongs to the category of the dizziness and headache of the traditional Chinese medical science, shows liver, and root is then vigorous at deficiency of kidney-YIN, liver-fire, and pathology disclose also that The liver and the kidney have a common source, essence and blood sharing the same origin.Therefore, according to motherland's medical science theory of " passages through which vital energy circulates leads to, cures mainly in one's power ", by Yongquan acupoint is carried out corresponding Drug therapy, make medicine infiltrate through the skin meridians, in order to nourish kidney water, suppressing the hyperactive liver and subsiding YANG, activation blood vessels, will help to improve the blood of human body circulation undoubtedly and realize prevention and treatment multiple diseases such as hypertension and cardiovascular and cerebrovascular diseases.
Core bag of the present invention is a kind of drug osmotic device by treatment of human body vola Yongquan acupoint and prophylaxis of hypertension disease, it have one can support be attached to Yongquan acupoint position, vola and in the silk manufacturing lining core bag of Chinese medicine medicated powder medicated core is housed, medicated core is made with cotton, and institute's powder charge thing is formed by human blood-pressure is reduced useful Ramulus Uncariae Cum Uncis, Concha Ostreae, Haematitum, Cornu Naemorhedi, Pheretima, Radix Achyranthis Bidentatae, Scorpio, Spica Prunellae, Rhizoma Chuanxiong, the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Flos Chrysanthemi, Fructus Liquidambaris, Fructus Aurantii, Rhizoma Zingiberis Recens, Radix Saposhnikoviae in it.During use, the core bag supported being attached to Yongquan acupoint place, vola, like this, under human pressure and body temperature effect, active drug composition in the medicated core will slowly release, directly infiltrate through the skin meridians through Yongquan acupoint, and then promote telangiectasis in the human body, accelerate blood circulation, remove the congestive state of patient's brain, regulate patient's vegetative nerve, hormonal system and corticocerebral function, make it to reach that QI and blood is smooth, negative and positive flat, thereby also reached the effect of blood pressure lowering.
The proportioning value that constitutes the every part of prescription medicine of adorning in the medicated core is: 15～25 unit of weights of Ramulus Uncariae Cum Uncis; 25～40 unit of weights of Concha Ostreae; 28～35 unit of weights of Haematitum; 3～8 unit of weights of Cornu Naemorhedi; 15～30 unit of weights of Pheretima; 10～30 unit of weights of Radix Achyranthis Bidentatae; 5～15 unit of weights of Scorpio; 10～25 unit of weights of Spica Prunellae; 10～15 unit of weights of Rhizoma Chuanxiong; 12～20 unit of weights of the Radix Astragali; 10～15 unit of weights of Radix Angelicae Sinensis; 20～25 unit of weights of the Radix Rehmanniae; 15～20 unit of weights of Radix Rehmanniae Preparata; 10～25 unit of weights of the Radix Paeoniae Alba; 15～20 unit of weights of Flos Chrysanthemi; 15～25 unit of weights of Fructus Liquidambaris; 5～12 unit of weights of Fructus Aurantii; 5～30 unit of weights of Rhizoma Zingiberis Recens; 5～15 unit of weights of Radix Saposhnikoviae.
In the said medicine prescription, the effect of Ramulus Uncariae Cum Uncis, Concha Ostreae, Haematitum is heat clearing away suppressing the hyperactive liver, important city YANG hyperactivity suppressing, endogenous wind stopping relieving convulsion and hard masses softening and resolving, is to be monarch drug; The effect of the Radix Astragali, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Scorpio, Cornu Naemorhedi, Flos Chrysanthemi, Pheretima is QI invigorating, YIN nourishing, nourishes blood, invigorates blood circulation, relieves dizziness, high fever, infantile convulsions, epilepsy, etc., spasmolytic is calmed the nerves, diuretic, removing heat from blood, spasmolytic, is to be ministerial drug; The effect of the Radix Rehmanniae, Radix Achyranthis Bidentatae, Fructus Liquidambaris, Rhizoma Chuanxiong, Spica Prunellae, Fructus Aurantii is that liver nourishing the moon, invigorating the liver and kidney, conducting blood to flow downwards, dispelling, collateral-activating, diuretic stimulate the menstrual flow, regulating the flow of QI to ease the stomach, liver heat removing eliminating stagnation, is to be adjuvant drug; The effect of Rhizoma Zingiberis Recens, Radix Saposhnikoviae is to induce sweat, dispels the wind, cold expelling, harmonizing yingfen and weifen, is to be messenger drug.Make a general survey of all medicine compatibilities of full side, play altogether that nourishing YIN for suppressing the hyperactive YANG, suppressing the hyperactive liver to relieve the wind syndrome, benefiting qi and nourishing blood, spasmolytic are calmed the nerves, the effect of promoting blood circulation and cooling blood, the gentle muscle of YIN nourishing, removing heat-phlegm, dredge the meridian passage, expelling wind to relieve convulsion.
The actual fabrication structure of core bag product of the present invention mainly contains two kinds, the structure that the first is connected with footwear, promptly on the following core face of silk manufacturing lining core bag, be provided with and bag can be bonded in the adhesive tape that the footwear inner bottom surface is positioned at patient's Yongquan acupoint position, the patient is worn just can implement treatment behind the footwear; Another kind of structure be with said silk manufacturing lining core bag make one can contain vola open type binder shape core bag, be positioned at Yongquan acupoint position, vola at core bag middle part and be provided with the medicated core that fills Chinese medicine medicated powder, during use that the core band is coated on patient's vola and make in the band medicated core be positioned at the vola Yongquan acupoint to sentence the treatment of realization to hypertension.
Embodiment:
Adopt the open type bandage structure, its core band is made by the elastic cord polycot blend fabric, and medicated core is that cotton is made, interior powder charge powder 40 grams.The proportioning value of each ingredient is in the medicated powder prescription: Ramulus Uncariae Cum Uncis 20, Concha Ostreae 30, Haematitum 30, Cornu Naemorhedi 5, Pheretima 15, Radix Achyranthis Bidentatae 15, Scorpio 5, Spica Prunellae 12, Rhizoma Chuanxiong 10, the Radix Astragali 15, Radix Angelicae Sinensis 10, the Radix Rehmanniae 20, Radix Rehmanniae Preparata 15, the Radix Paeoniae Alba 12, Flos Chrysanthemi 15, Fructus Liquidambaris 15, Fructus Aurantii 6, Rhizoma Zingiberis Recens 6, Radix Saposhnikoviae 5.
Case observation and curative effect:
Clinical case 102 examples of observing altogether, wherein TCM Syndrome Type is the hepatic and renal YIN deficiency, liver-Yang sthenia type 68 examples, is negative and positive empty type 34 examples of holding concurrently.
1, therapeutic modality: with the described product of embodiment every night directly cover spread on arch of the foot, medicated core is aimed at Yongquan acupoint, and antihypertensive effect was promptly arranged in general 12 hours, and is too fast and cause uncomfortablely as blood pressure lowering, can treat that the sense of discomfort back that disappears continues to use.Every secondary core bag can use 45～60 days continuously, noted being kept at the hermetically drying place daytime.
2, criterion of therapeutical effect: curative effect is divided produce effects, effective, invalid Three Estate, and concrete criterion is as follows:
A) it is normal that produce effects---blood pressure recovers, and follows up a case by regular visits to and do not recur January, and General Symptoms and sign obviously alleviate, doing well,improving rate 〉=75%;
B) effective---blood pressure descends to some extent, and symptom and sign alleviates, doing well,improving rate 〉=25%;
C) invalid---blood pressure no change, the basic no change of symptom and sign;
3, general curative effect result: this organizes 102 routine case histories after treatment, produce effects 48 examples, and effective 47 examples, invalid 7 examples, total effective rate is 93.1%, obvious effective rate is 47.1%.
Claims (3)
1, a kind of core bag that treatment hypertension Chinese medicine medicated powder is housed, it is characterized in that having one can support be attached to Yongquan acupoint position, vola and in the silk manufacturing lining core bag of Chinese medicine medicated powder medicated core is housed, institute's powder charge thing is made up of Ramulus Uncariae Cum Uncis, Concha Ostreae, Haematitum, Cornu Naemorhedi, Pheretima, Radix Achyranthis Bidentatae, Scorpio, Spica Prunellae, Rhizoma Chuanxiong, the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Flos Chrysanthemi, Fructus Liquidambaris, Fructus Aurantii, Rhizoma Zingiberis Recens, Radix Saposhnikoviae in medicated core, and the proportioning value of each medicine is: 15～25 unit of weights of Ramulus Uncariae Cum Uncis; 25～40 unit of weights of Concha Ostreae; 28～35 unit of weights of Haematitum; 3～8 unit of weights of Cornu Naemorhedi; 15～30 unit of weights of Pheretima; 10～30 unit of weights of Radix Achyranthis Bidentatae; 5～15 unit of weights of Scorpio; 10～25 unit of weights of Spica Prunellae; 10～15 unit of weights of Rhizoma Chuanxiong; 12～20 unit of weights of the Radix Astragali; 10～15 unit of weights of Radix Angelicae Sinensis; 20～25 unit of weights of the Radix Rehmanniae; 15～20 unit of weights of Radix Rehmanniae Preparata; 10～25 unit of weights of the Radix Paeoniae Alba; 15～20 unit of weights of Flos Chrysanthemi; 15～25 unit of weights of Fructus Liquidambaris; 5～12 unit of weights of Fructus Aurantii; 5～30 unit of weights of Rhizoma Zingiberis Recens; 5～15 unit of weights of Radix Saposhnikoviae.
2, the core bag that treatment hypertension Chinese medicine medicated powder is housed as claimed in claim 1 is characterized in that being provided with adhesive tape on the following core face of silk manufacturing lining core bag.
3, the core bag that treatment hypertension Chinese medicine medicated powder is housed as claimed in claim 1, it is characterized in that said silk manufacturing lining core bag is an open type binder shape core bag that can contain vola, be positioned at Yongquan acupoint position, vola at core bag middle part and be provided with the medicated core that fills Chinese medicine medicated powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00113963 CN1212128C (en) | 2000-11-03 | 2000-11-03 | Blood circulation activating core |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00113963 CN1212128C (en) | 2000-11-03 | 2000-11-03 | Blood circulation activating core |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1351870A CN1351870A (en) | 2002-06-05 |
| CN1212128C true CN1212128C (en) | 2005-07-27 |
Family
ID=4583696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00113963 Expired - Fee Related CN1212128C (en) | 2000-11-03 | 2000-11-03 | Blood circulation activating core |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1212128C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100337660C (en) * | 2005-08-25 | 2007-09-19 | 贺拴友 | Hypertension treating Chinese medicine composition |
| CN101829242B (en) * | 2010-05-17 | 2011-10-05 | 广东养美医药投资有限公司 | Footbath effervescent tablet for preventing and treating hypertension |
-
2000
- 2000-11-03 CN CN 00113963 patent/CN1212128C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1351870A (en) | 2002-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766773B (en) | Chinese medicine prescription for treating talagia | |
| CN102000216A (en) | Traditional Chinese medicine foot bath prescription for treating hypertension | |
| CN101537060B (en) | Medicine for treating AIDS | |
| CN104367972A (en) | Traditional Chinese medicine composition for treating insomnia and preparation method thereof | |
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN1030183A (en) | A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use | |
| CN1212128C (en) | Blood circulation activating core | |
| CN101961452A (en) | Method for preparing neck and waist rehabilitation medicinal plaster for treating osteoproliferation | |
| CN102228584A (en) | Chinese medicinal preparation for treating helosis | |
| CN1411844A (en) | Weight-reducing Chinese medicine acted on acupoint | |
| CN101185695B (en) | Externally-applied traditional Chinese medicine for treating toothache | |
| CN103961569A (en) | Foot bath medicine bag | |
| CN103041085B (en) | Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN101703638A (en) | Pressure-relieving rehabilitation paste | |
| CN101129509A (en) | Medicament for treating diseases of genitalia and rectum | |
| CN101049364B (en) | Umbilicus pasted powder for eliminating hernia | |
| CN112245550A (en) | A Chinese medicinal composition with effect in regulating emotion, and its preparation method | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN103933274A (en) | Traditional Chinese medicine preparation for treating periodontitis | |
| CN101698048A (en) | Traditional Chinese medicine ointment for treating high blood pressure and preparation method thereof | |
| CN102068615B (en) | Chinese medicinal liquid for treating sciatica | |
| CN1228324A (en) | Traditional Chinese medicinal plaster-Baiqigao for curing rheumatism, sciatica and traumatic injury | |
| CN1048889C (en) | Physique-strengthening wind-dispelling plaster | |
| CN2277786Y (en) | Depressing bag used in acupuncture point Yongquan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |